| Pharmaceutical active ingredients: |
| Calcium BorogluconateDextroseMagnesium BorogluconatePhosphorus |
| Available forms, composition and doses of Norcalciphos: |
| Injectable; Injection; Calcium Borogluconate 26.04%; Dextrose 15%; Magnesium Borogluconate 6%; Phosphorus 0.5% |
| Norcalciphos medical category: |
| Veterinary; Pet Meds:CatsDogs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| ATCICD-10 |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| PfizerNorden Laboratories |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Norboral | Glyburide | Silanes Laboratorios |
| Norcain | Benzocaine | Unidentified Pharmaceutical Company |
| Norcaine | Benzocaine | Unidentified Pharmaceutical Company |
| Norcainum | Benzocaine | Unidentified Pharmaceutical Company |
| Norcalcin | Calcitonin | Biomedica-Chemica |
| Norcephin | Ceftriaxone Sodium | Alkem Laboratories; Cris Pharma House |
| Norcept | Ethinyl Estradiol; Norethindrone | Unidentified Pharmaceutical Company |
| Norcept-E | Ethinyl Estradiol; Norethindrone | Ortho McNeil Pharmaceuticals; GynoPharma |
| Norcet | Acetaminophen; Hydrocodone Bitartrate | Abana; King Pharmaceuticals |
| Norcholesterol Iode, I-131 | 6-Iodomethylnorcholesterol, I-131 | CIS Bio International |